| Literature DB >> 20350775 |
Alexandra Sawyer1, Susan Ayers, Andy P Field.
Abstract
There is increasing research on posttraumatic growth after life-threatening illnesses such as cancer and HIV/AIDS, although it is unclear whether growth confers any psychological or physical benefits in such samples. Consequently, this meta-analysis explored the relationship between posttraumatic growth and psychological and physical wellbeing in adults diagnosed with cancer or HIV/AIDS and examined potential moderators of these relationships. Analysis of 38 studies (N=7927) of posttraumatic growth after cancer or HIV/AIDS revealed that growth was related to increased positive mental health, reduced negative mental health and better subjective physical health. Moderators of these relationships included time since the event, age, ethnicity, and type of negative mental health outcome. It is hoped that this synthesis will encourage further examination of the potentially complex relationship between posttraumatic growth and adjustment in individuals living with life-threatening medical conditions.Entities:
Mesh:
Year: 2010 PMID: 20350775 PMCID: PMC7115708 DOI: 10.1016/j.cpr.2010.02.004
Source DB: PubMed Journal: Clin Psychol Rev ISSN: 0272-7358
Fig. 1Flow chart of systematic search.
Characteristics of studies included in the meta-analysis.
| Study | Health event | Mean age (range) | Sex composition | Racial composition | Mean time since occurrence | Measure of growth | Quality | |
|---|---|---|---|---|---|---|---|---|
| 308 | Non-Hodgkins Lymphona | 60 (23–85) | 51.3% male, 48.7% female | 30% Hispanic | 42 months | Close ended | 3 | |
| 763 | Breast cancer | 56 (3 0–87) | 100% female | 83.7% White, 8.7% Black, 7.6% Other | 40.8 months | Close ended | 3 | |
| 264 | HIV/AIDS | 40 | 49% male, 51% female | 49% African American, 25% Caucasian, 13% Hispanic | 7.7 years | BFS (a) | 4 | |
| 253 | Cancer (Mixed) | 58 (28–86) | 78% female, 22% male | 95% White | 7 months | Spiritual transformation scale | 4 | |
| 70 | Breast cancer | 55 (27–87) | 100% female | 90% White, 9% Black, 1% Other | 24 months | PTGI | 4 | |
| 92 | Breast cancer | 52 (25–72.8) | 100% female | 86% White | 9.4 months | PTGI | 4 | |
| 135 | Bone marrow transplant | 31 (18–53) | 61% male, 39% female | 91% White | 47 months | Open ended | 4 | |
| 90 | Bone marrow transplantation | 39 | 58% male, 42% female | NR | 49.5 months | Open ended | 3 | |
| 76 | Head and neck cancer | 66.9 (32–97) | 51% female, 49% male | 93% White, 7% Other | 34% 73–121 months, 25% 48–72 months, 41% < 48 months posttreatment | BFS (a) | 4 | |
| 188 | Cancer (Mixed) | 49 (26–69) | 17% male, 83% female | Chinese | > 5 years disease free | PTGI Chinese version | 3 | |
| ( | 773 | HIV/AIDS | 36 (19–55) | 100% women | 60% Black, 20% Latina, 20% White/Other | NR | Close ended | 3 |
| 294 | Cancer | 56 (21–84) | 28% male, 72% female | NR | 3.90 years | PTGI (in Dutch) | 4 | |
| 87 | Cancer and lupus | 53 | 13% male, 87% female | 73% White, 6% Black, 2% Asian, 12% Hispanic, 8% Other | 9 years | BFS (b) | 3 | |
| 250 | Prostate cancer | 65 | 100% male | 41% White, 17% Black, 42% Hispanic | 15.7 months | BFS (a) | 4 | |
| 100 | Cancer (mixed) | 53 | 42% female, 58% male | NR | 40% 1 year, 20% 2 years, 25% 2–5 years, 15% 5+ years | Close ended | 2 | |
| 221 | HIV/AIDS | 40 (22–59) | 44% female, 56% male | 42% African American, 46% Caucasian, 4% Native American, 4% Asian Pacific Islander, 4% Other | 7 years | BFS (a) | 4 | |
| 104 | HIV/AIDS | 35 (18–54) | 36% male, 64% female | 100% Indian | < 5 years | BFS (a) | 3 | |
| 835 | HIV/AIDS | 38 | 87% male, 13% female | 40% White, 37% Hispanic, 17% Black, 7% Other | 6.4 years | Items from PTGI | 4 | |
| 412 | HIV/AIDS | 39 | 88% male, 12% female | 39% White, 40% Hispanic, 15% African American, 6% Other | 6.4 years | Items from PTGI | 4 | |
| 183 | Breast cancer | 100% female | NR | NR | PTGI | 3 | ||
| 161 | Breast cancer | 59 (36–87) | 100% female | 85% White, 12% African American | 4 years | PTGI | 3 | |
| ( | 54 | Cancer | 60 (36–84) | 27.6% male 72.4% female | NR | 55.2% < 3 years, 44.8 ≥ 3 years | PTGI | 4 |
| ( | 100 | Breast cancer | 58.2 (31–81) | 100% female | NR | 6.1 years | PTGI | 4 |
| 172 | Cancer (mixed) | 45.2 | 69% female, 31% male | 88% White, 5% Latino, 3% Black/African American, 2% Native American | 23.4 months since primary treatment | PBS | 5 | |
| 52 | Breast cancer | 54 | 100% female | 92% European, 4% Maori, 4% other | 3 months posttradiation | Open ended | 3 | |
| 200 | Cancer (mixed) | 17% < 50, 45% 50–65, 38% > 75 | 58% male, 42% female | NR | Median = 52 weeks | Close ended | 3 | |
| 55 | Colorectal cancer | 65.9 | 58.9% female, 41.1% male | NR | 12 months | PTGI | 4 | |
| 113 | Cancer (mixed) | 51.8 (17–85) | 66.4% female, 33.5% male | 82.3% Chinese, 11.5% Malay | 45 months | PTGI | 3 | |
| 105 | Cancer (mixed) | 62 (19–86) | 61% male 39% female | NR | 1 month postsurgery | BFS (a) | 3 | |
| 117 | Cancer surgery | 62 | 62% male 38% female | NR | NR | Close ended | 3 | |
| 60 | Breast cancer | 52 (28–76) | 100% female | 87% White, 7% Black, 3% Latina, 1% Asian American, 1% Native American | 80 weeks | PTGI | 3 | |
| 138 | HIV/AIDS | 38 (22–48) | 100% female | 38% African American, 34% Puerto Rican, 28% White | 87.6 months | Thriving scale | 4 | |
| 82 | Prostate cancer | 61 (41–78) | 100% male | 90% White | NR | PTGI | 4 | |
| 364 | Breast cancer | 48 (25–75) | 100% female | 93% White, 6% Black, 1% Hispanic | 4 months | BFS (a) | 3 | |
| 189 | HIV | 37 (19–62) | 100% female | 48% Black, 33% White, 20% Latina | 4.65 years | Open ended | 3 | |
| 230 | Breast cancer | 54 (27–87) | 100% female | 63% White, 27% Hispanic, 10% Black | 3–12 months post surgery | BFS (a) | 4 | |
| 72 | Cancer–Bone marrow transplantation | 48 (25–66) | 26% male, 74% female | 85% White, 7% Black, 8% Hispanic | 24.05 | PTGI | 4 | |
| 165 | Cancer (mixed) | 45.7 (22–55) | 33% male, 67% female | 89% White | 3.5 years | BFS (a) | 5 |
NR = Not reported in the study; PTGI = Posttraumatic Growth Inventory; SRGS – Stress Related Growth Scale; PBS – Perceived Benefits Scale; BFS (a) = Benefit Finding Scale (Antoni et al., 2001); BFS (b) = Benefit Finding Scale (Mohr et al., 1990); SLQ – Silver Lining Questionnaire.
Stem and leaf plot of effect sizes for positive mental health (rs).
| Stem | Leaf |
|---|---|
| .4 | 4, 9 |
| .3 | 2 |
| .2 | 0, 3, 5, 5, 6 |
| .1 | 2 |
| .0 | 0, 3, 4, 4, 5, 9 |
| −.0 | 1, 9, 9 |
| −.1 | |
| −.2 | 3 |
Stem and leaf plot of effect sizes for negative mental health (rs).
| Stem | Leaf |
|---|---|
| .2 | 3, 4, 5, |
| .1 | 0, 1, 1, 3, 3, 4, 6, 6, |
| .0 | 0, 1, 2, 2, 2, 2, 3, 3, 4, 5, 5, 9, 9, 9 |
| −.0 | 1, 4, 4, 4, 5, 8, 9, 9 |
| −.1 | 0, 0, 1, 1, 1, 2, 2, 3, 3, 3, 7, 7, 9 |
| −.2 | 0, 0, 2, 3, 3, 4, 7, 7 |
| −.3 | 3, 4, 5, 6 |
| −.4 | 2, 4, |
Stem and leaf plot of effect sizes for subjective physical health (rs).
| Stem | Leaf |
|---|---|
| .6 | 4 |
| .5 | |
| .4 | 5, 7 |
| .3 | |
| .2 | 5 |
| .1 | 1, 4 |
| .0 | 0, 0, 4, 8, 9 |
| −.0 | 2, 1, 1, 7 |
| −.1 | 3, 7 |
Meta-analysis results for each adjustment outcome.
| Adjustment | 95% confidence interval for | ||||||
|---|---|---|---|---|---|---|---|
| Lower | Mean | Upper | |||||
| Positive mental health | 19 | .027 | 119.04 | .04 | .13 | .21 | 3.00 |
| Negative mental health | 60 | .029 | 360.58 | −.10 | −.05 | −.01 | − 2.17 |
| Subjective physical health | 17 | .053 | 219.51 | .00 | .12 | .23 | 1.95 |
k = number of effect sizes, Q = homogeneity statistic.
p < .05.
p < .01.
p < .001.
Fig. 2Funnel plot of positive mental health. The vertical line is the population effect size and the diagonal line displays the 95% confidence interval.
Fig. 3Funnel plot of negative mental health. The vertical line is the population effect size and the diagonal line displays the 95% confidence interval.
Fig. 4Funnel plot of subjective physical health. The vertical line is the population effect size and the diagonal line displays the 95% confidence interval.